205 related articles for article (PubMed ID: 33576586)
21. Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study.
Deveci K; Gokakin AK; Boztosun A; Deveci H; Senel S; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):261-5. PubMed ID: 23377818
[TBL] [Abstract][Full Text] [Related]
22. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
23. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.
Stankovic Stojanovic K; Hentgen V; Fellahi S; Georgin-Lavialle S; Amselem S; Grateau G; Bastard JP; Steichen O
Clin Biochem; 2017 Mar; 50(4-5):206-209. PubMed ID: 27838405
[TBL] [Abstract][Full Text] [Related]
24. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
25. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF).
Guzel S; Andican G; Seven A; Aslan M; Bolayirli M; Guzel EC; Hamuryudan V
Mod Rheumatol; 2012 Jun; 22(3):431-7. PubMed ID: 21947799
[TBL] [Abstract][Full Text] [Related]
26. R202Q/M694V as novel MEFV gene mutations in chronic periodontitis and familial Mediterranean fever.
Fentoğlu Ö; Dinç G; Bağcı Ö; Doğru A; İlhan I; Kırzıoğlu FY; Orhan H
J Periodontal Res; 2017 Dec; 52(6):994-1003. PubMed ID: 28590056
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with Familial Mediterranean fever.
Uluca Ü; Ece A; Şen V; Karabel D; Yel S; Güneş A; Tan I; Sabas M
Med Sci Monit; 2014 Sep; 20():1578-82. PubMed ID: 25189760
[TBL] [Abstract][Full Text] [Related]
28. Serum leptin is not a diagnostic marker for familial Mediterranean fever attacks.
Toy B; Tarçin O; Bağci S; Ustündağ Y; Inal A; Tiftikçi A
Mediators Inflamm; 2006; 2006(2):62868. PubMed ID: 16883064
[TBL] [Abstract][Full Text] [Related]
29. The frequency of fibromyalgia in familial Mediterranean fever and its impact on the quality of life.
Altıntas D; Melikoglu MA
Int J Rheum Dis; 2022 Oct; 25(10):1123-1128. PubMed ID: 35851993
[TBL] [Abstract][Full Text] [Related]
30. Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever.
Gunay Y; Karagozlu F; Gemici S; Yilmaz SS; Sahin S; Barut K; Kasapcopur O; Dedeoglu R
Eur J Pediatr; 2024 Jul; 183(7):3137-3145. PubMed ID: 38668795
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory bio- marker or familial Mediterranean fever disease.
Akyol T; Düzenli T; Tanoğlu A
Turk J Med Sci; 2021 Apr; 51(2):813-818. PubMed ID: 33306334
[TBL] [Abstract][Full Text] [Related]
33. Continuity of cytokine activation in patients with familial Mediterranean fever.
Bagci S; Toy B; Tuzun A; Ates Y; Aslan M; Inal A; Gulsen M; Karaeren N; Dagalp K
Clin Rheumatol; 2004 Aug; 23(4):333-7. PubMed ID: 15293095
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods.
Gok M; Sirkeci O; Kara M; Sakin YS; Tanoglu A; Sirkeci EE; Oztin H; Duzenli T; Kaplan M; Yazgan Y; Ipcioglu OM
Bratisl Lek Listy; 2018; 119(8):490-493. PubMed ID: 30160156
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of anti-interleukin-1 therapy on subclinical inflammation parameters during the attack-free period in familial Mediterranean fever patients: A case-control study.
Atalar E; Doğan İ; Gök K; Güven SC; Maraş Y; Ceylan GG; Erten S
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161616
[TBL] [Abstract][Full Text] [Related]
36. Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever.
Karatay S; Yildirim K; Uyanik A; Uzkeser H; Kiziltunc A; Ugur M; Baygutalp F; Acemoglu H
Ann Clin Lab Sci; 2010; 40(1):10-4. PubMed ID: 20124324
[TBL] [Abstract][Full Text] [Related]
37. Trace element levels in patients with familial mediterranean Fever.
Yildirim K; Uzkeser H; Uyanik A; Karatay S; Kiziltunc A
Eurasian J Med; 2011 Aug; 43(2):79-82. PubMed ID: 25610168
[TBL] [Abstract][Full Text] [Related]
38. The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis.
Ugan Y; Korkmaz H; Dogru A; Koca YS; Balkarlı A; Aylak F; Tunc SE
Clin Rheumatol; 2016 Jul; 35(7):1669-72. PubMed ID: 26873102
[TBL] [Abstract][Full Text] [Related]
39. The value of procalcitonin measurements in children with familial Mediterranean fever.
Yüksel S; Ekim M; Ozçakar ZB; Yalçınkaya F; Acar B; Oztuna D; Akar N
Rheumatol Int; 2012 Nov; 32(11):3443-7. PubMed ID: 22057145
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic insights into Familial Mediterranean Fever: Increased RGS10 expression and histone modifications accompanies inflammation in familial Mediterranean fever disease.
Caldiran F; Deveci K; Cacan E
Gene; 2024 May; 906():148222. PubMed ID: 38331118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
